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SUMMARY
Mayaro virus (MAYV) is an arbovirus (Togaviridae: Alphavirus) enzootic in tropical South America and maintained in a
sylvan cycle involving wild vertebrates and Haemagogus mosquitoes. MAYV cases occur sporadically in persons with a history of
recent activities inside or around forests. This paper reports three cases of MAYV fever detected in men infected in Camapuã, MS,
Brazil. Serum samples collected at four days and two months after the onset of the symptoms and examined by hemagglutination
inhibition test, revealed monotypic seroconversion to MAYV. Isolation of the virus was obtained from one of the samples by
inoculation of the first blood samples into newborn mice. A suspension of the infected mouse brain was inoculated into C6/36 cells
culture and the virus was identified by indirect immunofluorescent assay with alphavirus polyclonal antibodies. RT-PCR, performed
with RNA extracted from the supernatant of C6/36 infected cells in the presence of alphavirus generic primers as well as specific
MAYV primers, confirmed these results. The reported cases illustrate the importance of laboratory confirmation in establishing a
correct diagnosis. Clinical symptoms are not always indicative of a disease caused by an arbovirus. Also MAYV causes febrile
illness, which may be mistaken for dengue.
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INTRODUCTION
Mayaro virus (MAYV) is an arbovirus member of the genus
Alphavirus, family Togaviridae. MAYV is enzootic to tropical South
America and endemic to rural areas. It is maintained in a sylvan cycle
involving wild vertebrates, including nonhuman primates and
Haemagogus mosquitoes12. Birds can act as secondary hosts, being
important for the dissemination of the virus2,20. Most of MAYV
infections are sporadic and occur in persons with a history of recent
activities inside or around forests; but several small outbreaks have
been reported in the Amazon Region, usually limited to rural areas
near or inside forests, where the vector is found4,10.
Mayaro fever is a non-fatal, typically dengue-like, acute febrile
illness, characterized by frontal headaches, epigastric pain, myalgias,
incapacitating arthralgias, maculopapular rash, chills, nausea,
photophobia and vertigo. The joint pain may persist for several
months11.
The first isolations of MAYV were made from blood of five febrile
forest workers in Trinidad in 19541. The virus has been responsible for
epidemics in South America and has been recovered from humans,
wild vertebrates and mosquitoes in Brazil, Bolivia, Colombia, French
Guiana, Guyana, Peru and Surinam16,18. Cases of MAYV were also
described among member of the same family in a semirural forested
area of Venezuela19. In addition, antibodies to MAYV have been found
in Costa Rica, Guatemala and Panamá12,13.
In Brazil the virus is endemic to the Amazon Region, where at
least four epidemics have been reported in Pará State; in a community
of quarry workers on the Guamá river, in 1955, in Belterra, a rural
village of rubber plantations in 1978, in Conceição do Araguaia in
1981 and in Benevides in 19914,10,20.
Two other outbreaks were registered in Itaruma, Goiás State, in
1987 and in Peixe, Tocantins State, in 199120. Specific antibodies against
MAYV was also found in Xavante indians of Mato Grosso State and in
inhabitants from rural areas of Goiás State in Central Brazil8,13.
Although high antibodies rates are found in some rural communities
of the Amazon basin of Brazil11, it is difficult to isolate MAYV, because
of the relatively short period of viremia20.
This report describes three cases of MAYV infection in São Paulo,
detected in patients infected while fishing in Camapuã, MS, from 11
to 19 March, 2000.
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MATERIAL AND METHODS
Case reports
Patient 1: SPH 191220, a 36 year-old male, resident of Flórida
Paulista, SP. Onset of the symptoms: 18 March 2000, high fever for
four days, arthralgias, joint pains in hand, knees and ankles
Patient 2: SPH 191221, a 59 year-old male, resident of Oswaldo
Cruz, SP. Onset of the symptoms: 20 March 2000, high fever,
arthralgias, joint pains in hands, knees and ankles for two days. He
was hospitalized from 21 to 23 March. The arthralgias lasted for a
month.
Patient 3: SPH 191223, a 74 year-old male, resident of Oswaldo
Cruz, SP. Onset of the symptoms: 18 March 2000, high fever for two
days. The artrhalgias lasted for a month with joints edema.
All patients showed a good course with full recovery.
Laboratorial assays: Blood samples were collected four days after
the onset of the symptoms (acute) and two months later (convalescent).
Serological tests with acute and convalescent sera samples were
performed by hemagglutination inhibition (HI) method with acetone-
extracted serum samples15, employing four units of the following
antigens produced in suckling mice brain: Alphavirus (Eastern,
Venezuelan and Western equine encephalitis viruses, and Mayaro virus),
Flavivirus (Dengue 1, 2 and 3, Iguape, Ilheus, Rocio, St. Louis
encephalitis and Yellow fever viruses) and Orthobunyavirus (Caraparu
virus). The antigens were produced in Adolfo Lutz Institute.
All sera samples were also processed for Dengue virus (DENV)
IgM by MAC-ELISA7.
The acute serum samples were inoculated intracerebrally into
newborn mice, which were observed for 21 days. A suspension of
infected mouse brain from the sick or dead mice was inoculated onto
C6/36 mosquito cells, incubated at 28 0C for nine days, and then
examined by indirect immunofluorescent assay (IFA)17 with alphavirus
polyclonal antibodies.
Molecular assay was performed with RNA extracted from a
supernatant of infected C6/36 cells using the QIAmp ViralRNA Extraction
Kit (Quiagen, Valencia, CA, USA) according to manufacture’s
instructions. The SuperScriptTM One Step RT-PCR System with Platinium
Taq DNA Polymerase (Invitrogen, Carlsbad, CA, USA) was used for
RT-PCR, in a final volume of 25 µL, containing 5 µL of viral RNA and
10 pMol of the M2W/cM3W genus-specific alphavirus primers9 as well
as the MayF1/MayB2 specific MAYV primers16 (Table 1). Reverse
transcription was performed at 50 °C for 30 min. After a 2-min
denaturation step at 94 °C, the samples were thermocycled using the
following program: denaturation at 94 °C for 30 sec, primer annealing
at 55 °C for one min, extension at 72 °C for two min for 35 cycles, and
a final extension at 72 °C for seven min. The amplification products
were analyzed by electrophoresis in a 1.5% agarose gel, and the separated
fragments were visualized by ethidium bromide staining.
Table 1
Alphavirus genus-specific and MAYV specific primers used in RT-PCR
Primer Sequence Nucleotide Orientation PCR product
position (bp)***
M2W* (CT)AGAGC(AGT)TTTTCGCA(CT)(GC)T(AG)GC(ACT)(AT) 164-186 Forward 434
cM3W ACAT(AG)AAN(GT)GNGTNGT(AG)TC(AG)ANCC(AGT)A(CT)CC 568-597 Reverse
MayF1** CTTCCCATGTTTCCAACCGAG 8235-8255 Forward 462
MayB2 GCCAGGATAAAGTGTCCCATTGTG 8696-8673 Reverse
*Alphavirus genus-specific primers9, encompassing the 5’ end of the nsP1 gene of the Venezuelan equine encephalitis virus genome reported by KINNEY et al. (1992).
**MAYV specific primers16, encompassing the envelope E3 and E2 portion of the MAYV virus genome. *** base pair.
Fig. 1 - Ethidium bromide-stained agarose gel showing the products resulting from RT-PCR
amplification performed with Alphavirus genus-specific primers, MAYV specific primers,
RNA extracted from the patient (lanes 2 and 5) and MAYV positive control (lanes 3 and 6),
respectively. Negative controls are shown in lanes 4 and 7 and molecular markers are shown
in lane 1.
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RESULTS
Virus isolation was obtained from only one of the acute blood
samples (SPH 191221). All of the convalescent sera samples revealed
monotypic seroconversion to MAYV by HI, with titer of 1:80 in the 2nd
sera samples. Although this titer can be considered low, it is compatible
with the period between the first and second samples. MAC-ELISA
was not reactive to DENV. IFA done on the C6/36 cells was positive
for alphavirus. This result was confirmed by the RT-PCR assay, done
with the viral RNA and genus-specific alphavirus primers (Table 1). A
final identification of MAYV virus was obtained in a further RT-PCR
assay, performed with specific MAYV primers, designed to amplify a
462 base-pair product from the envelope E3 and E2 portion of the
genome16 (Table 1).
DISCUSSION
Arboviruses infections cannot usually be diagnosed only based on
clinical symptoms; MAYV for example, causes a febrile illness that
may be mistaken for DENV or other exanthematous diseases5. For this
reason, many cases may be misdiagnosed. The surveillance system to
diagnose acute undifferentiated febrile syndromes in the western
Amazonian region of Brazil, analyzes serum samples obtained from
patients with clinical suspicion of dengue and IgM antibodies to MAYV
have been detected in a number of cases5. In addition, during two related
epidemics of MAYV in the Amazonia, occurred concurrently with
yellow fever12; and virological and serological studies made possible
the differentiation of both diseases. Thus, the related cases illustrate,
once more, the importance of laboratory confirmation in establishing
a correct diagnosis.
None of the three patients presented rash which is reportably
observed in about two thirds of MAYV infections, being more frequent
in children12. The brief viremia, that occurs during MAYV infections
may be responsible by the fact that the virus was isolated in only one
out of the three cases.
The detection of MAYV in Goiás and Mato Grosso8,13,20 and the
present cases in Mato Grosso do Sul indicates that the virus also occurs
out of the Amazonian Region.
It is noteworthy to consider the possibility of urbanization of the
disease. Although mosquitoes of the genus Haemagogus are presumed
to be the principal vector of the virus, experimental studies indicate
that MAYV can also infect and be transmitted by Aedes aegypti1. So
potentially, it might be transmitted in urban areas under the appropriate
conditions.
Despite the fact that there are no fatal cases due to MAYV infection,
the disease may cause a significant morbidity among persons who live
in rural areas12. Intense arthralgia causes temporary incapacitation to
work and some severely affected patients require hospitalization.
Consequently, epidemics might have an important social and economic
impact.
Infections by MAYV virus are sporadic; and as pointed out in this
study, affect susceptible persons who are exposed to mosquitoes in
forested areas. Human surveillance is difficult, since the infections are
sometimes asymptomatic and they occur in rural areas, near or inside
forests. Hence measures to control the vectors or vertebrates reservoirs
would be impractical. At present, avoiding mosquito bites remains the
only effective preventive control at present.
RESUMO
Vírus Mayaro: casos importados de infecção humana no Estado
de São Paulo, Brasil
O vírus Mayaro (MAYV) é um arbovírus do gênero Alphavirus,
família Togaviridae, enzoótico na América do Sul, sendo mantido em
ciclo silvestre envolvendo vertebrados e mosquitos Haemagogus. Casos
de MAYV são esporádicos e ocorrem em pessoas com história de
recentes atividades dentro ou próximo a florestas. Este artigo relata
infecção por MAYV detectada em três pacientes, infectados em
Camapuã, MS, Brasil. Amostras de sangue, coletadas no 4° dia e no 2°
mês após o início dos sintomas, foram usadas para teste de inibição da
hemaglutinação, que revelou soroconversão monotípica para MAYV.
O isolamento do vírus foi obtido somente de uma das amostras, por
inoculação em camundongos lactentes. Suspensão de cérebro de
camundongo infectado foi inoculada em cultura de células C6/36 e o
vírus foi identificado por imunofluorescência indireta com anticorpos
policlonais para alphavirus. RT-PCR realizado com RNA extraído do
sobrenadante de células C6/36 infectadas, na presença de “primers”
genéricos para alphavirus assim como “primers” para MAYV,
confirmou os resultados. Os casos relatados ilustram a importância da
confirmação laboratorial em estabelecer um diagnóstico correto. Os
sintomas clínicos não são sempre indicativos de uma doença causada
por arbovírus. MAYV causa doença febril, que pode ser confundida
com dengue.
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